§

Regeneron Pharmaceuticals, Inc.

PGR2021-00117 (P.T.A.B. Mar. 15, 2022)
Regeneron Pharmaceuticals, Inc.

4 Cited authorities

  1. Arthrex, Inc. v. Smith & Nephew, Inc.

    880 F.3d 1345 (Fed. Cir. 2018)   Cited 10 times   8 Legal Analyses

    2017-1239 01-24-2018 ARTHREX, INC., Appellant v. SMITH & NEPHEW, INC., ArthroCare Corp., Appellees Anthony P. Cho, Carlson, Gaskey & Olds, P.C., Birmingham, MI, argued for appellant. Also represented by David J. Gaskey, Birmingham, MI. Nathan R. Speed, Wolf, Greenfield & Sacks, PC, Boston, MA, argued for appellees. Also represented by Richard Giunta, Boston, MA, Michael N. Rader, New York, NY. Dyk, Circuit Judge. Anthony P. Cho, Carlson, Gaskey & Olds, P.C., Birmingham, MI, argued for appellant.

  2. Section 324 - Institution of post-grant review

    35 U.S.C. § 324   Cited 42 times   58 Legal Analyses
    Requiring threshold determination that it is "more likely than not that at least 1 of the claims . . . is unpatentable"

  3. Section 1.321 - Statutory disclaimers, including terminal disclaimers

    37 C.F.R. § 1.321   Cited 75 times   35 Legal Analyses
    Incorporating the language of § 253

  4. Section 42.207 - Preliminary response to petition

    37 C.F.R. § 42.207   Cited 5 times   6 Legal Analyses
    Permitting patent owner to file preliminary responses to petition for post-grant review